WO2002067894A3 - Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors - Google Patents
Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors Download PDFInfo
- Publication number
- WO2002067894A3 WO2002067894A3 PCT/IB2002/000587 IB0200587W WO02067894A3 WO 2002067894 A3 WO2002067894 A3 WO 2002067894A3 IB 0200587 W IB0200587 W IB 0200587W WO 02067894 A3 WO02067894 A3 WO 02067894A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- cyclooxygenase
- fast dissolving
- enzyme inhibitors
- dissolving tablets
- tablets
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Zoology (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP02702595A EP1367994A2 (en) | 2001-02-27 | 2002-02-27 | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
AU2002236120A AU2002236120A1 (en) | 2001-02-27 | 2002-02-27 | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
HU0400098A HUP0400098A2 (en) | 2001-02-27 | 2002-02-27 | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors and process for their preparation |
PL02363771A PL363771A1 (en) | 2001-02-27 | 2002-02-27 | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
SK1180-2003A SK11802003A3 (en) | 2001-02-27 | 2002-02-27 | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
IS6932A IS6932A (en) | 2001-02-27 | 2003-08-27 | Highly soluble cyclooxygenase-3 enzyme inhibitor tablets |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN189DE2001 | 2001-02-27 | ||
IN189/DEL/01 | 2001-02-27 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002067894A2 WO2002067894A2 (en) | 2002-09-06 |
WO2002067894A3 true WO2002067894A3 (en) | 2002-12-19 |
Family
ID=11097035
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/IB2002/000587 WO2002067894A2 (en) | 2001-02-27 | 2002-02-27 | Fast dissolving tablets of cyclooxygenase-2 enzyme inhibitors |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP1367994A2 (en) |
AU (1) | AU2002236120A1 (en) |
CZ (1) | CZ20032568A3 (en) |
HU (1) | HUP0400098A2 (en) |
IS (1) | IS6932A (en) |
OA (1) | OA12686A (en) |
PL (1) | PL363771A1 (en) |
SK (1) | SK11802003A3 (en) |
WO (1) | WO2002067894A2 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7815937B2 (en) | 1998-10-27 | 2010-10-19 | Biovail Laboratories International Srl | Quick dissolve compositions and tablets based thereon |
CN1638739A (en) * | 2000-08-18 | 2005-07-13 | 法玛西雅厄普约翰美国公司 | Compound for treating assuetude disturbance |
TR200301552A1 (en) * | 2003-09-18 | 2005-10-21 | Nobel İlaç Sanayi̇ Ve Ti̇caret A. Ş. | Novel oral pharmacological formulations of rofecoxib. |
GB0724707D0 (en) * | 2007-12-19 | 2008-01-30 | Burke Michael H | A process for the preparation of an orally administered unit dose tablet |
US10350171B2 (en) | 2017-07-06 | 2019-07-16 | Dexcel Ltd. | Celecoxib and amlodipine formulation and method of making the same |
CN108653225B (en) * | 2018-08-15 | 2021-01-08 | 湖北舒邦药业有限公司 | Nimesulide preparation and preparation method thereof |
CN112569178B (en) * | 2020-12-29 | 2022-09-09 | 南京百泽医药科技有限公司 | Preparation method of parecoxib pharmaceutical composition and application of parecoxib pharmaceutical composition as sublingual preparation |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0748628A2 (en) * | 1995-06-13 | 1996-12-18 | American Home Products Corporation | Oral formulations of S(+)-Etodolac |
EP0945134A1 (en) * | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | New galenic formulations of meloxicam for oral administration |
WO2001085134A1 (en) * | 2000-05-12 | 2001-11-15 | Emcure Pharmaceuticals Ltd | Pharmaceutical solid compositions and process for the production of mouth dissolving tablets |
-
2002
- 2002-02-27 OA OA1200300219A patent/OA12686A/en unknown
- 2002-02-27 EP EP02702595A patent/EP1367994A2/en not_active Withdrawn
- 2002-02-27 PL PL02363771A patent/PL363771A1/en not_active Application Discontinuation
- 2002-02-27 AU AU2002236120A patent/AU2002236120A1/en not_active Abandoned
- 2002-02-27 SK SK1180-2003A patent/SK11802003A3/en unknown
- 2002-02-27 HU HU0400098A patent/HUP0400098A2/en unknown
- 2002-02-27 CZ CZ20032568A patent/CZ20032568A3/en unknown
- 2002-02-27 WO PCT/IB2002/000587 patent/WO2002067894A2/en not_active Application Discontinuation
-
2003
- 2003-08-27 IS IS6932A patent/IS6932A/en unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0748628A2 (en) * | 1995-06-13 | 1996-12-18 | American Home Products Corporation | Oral formulations of S(+)-Etodolac |
EP0945134A1 (en) * | 1998-03-27 | 1999-09-29 | Boehringer Ingelheim Pharma KG | New galenic formulations of meloxicam for oral administration |
WO2001085134A1 (en) * | 2000-05-12 | 2001-11-15 | Emcure Pharmaceuticals Ltd | Pharmaceutical solid compositions and process for the production of mouth dissolving tablets |
Also Published As
Publication number | Publication date |
---|---|
HUP0400098A2 (en) | 2004-04-28 |
SK11802003A3 (en) | 2004-06-08 |
CZ20032568A3 (en) | 2004-04-14 |
PL363771A1 (en) | 2004-11-29 |
EP1367994A2 (en) | 2003-12-10 |
IS6932A (en) | 2003-08-27 |
WO2002067894A2 (en) | 2002-09-06 |
OA12686A (en) | 2006-06-21 |
AU2002236120A1 (en) | 2002-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2004112711A3 (en) | Oral extended-release composition | |
MXPA03006476A (en) | Pharmaceutical dosage forms of epothilones for oral administration. | |
WO2008085765A3 (en) | Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain | |
AU2003229555A1 (en) | Oral administration form for difficulty soluble basic active ingredients which are applied orally | |
WO2005065646A3 (en) | Novel drug compositions and dosage forms | |
EP1893182B8 (en) | Oral dosage forms comprising progesterone and method of making and using the same | |
AU2002357012A1 (en) | Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof | |
WO2001056544A3 (en) | Shell-and-core dosage form approaching zero-order drug release | |
WO2001090091A8 (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
WO2001032183A3 (en) | Pharmaceutical compositions comprising oxcarbazepine | |
NO20042596L (en) | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 | |
WO2007012019A3 (en) | Medicaments containing famotidine and ibuprofen and administration of same | |
WO2008142572A3 (en) | Controlled release tablet formulation containing magnesium aluminometasilicate | |
WO2007009806A3 (en) | Solid dosage formulations of narcotic drugs having improved buccal adsorption | |
WO2001022791A8 (en) | Controlled release compositions comprising nimesulide | |
AU2003270255A1 (en) | Fast releasing, solid administration form for oral application of active ingredients which are hard to dissolve | |
ATE454132T1 (en) | TABLET THAT MELTS QUICKLY IN THE ORAL CAVITY | |
WO2008049657A3 (en) | Use of (meth)acrylate copolymers in slow-release pharmaceutical forms for reducing the influence of ethanol on active ingredient release | |
ZA200303037B (en) | Herbal pharmaceutical composition for treatment of HIV/Aids patients. | |
IS7006A (en) | Dihydrogen 3-piperidinopropiophenone and medicinal products containing said compounds | |
WO2006097943A3 (en) | Pharmaceutical compositions of amlodipine and benazepril | |
WO2004032866A3 (en) | Therapeutic formulations | |
HUP0301390A2 (en) | Oral pharmaceutical composition containing valsartan | |
EA201001108A1 (en) | TABLETS DISPENSABLE IN THE Mouth OF THE TABLET, CONTAINING THE BASIS OF THE ESCITALOPRAM, AND METHOD OF THEIR RECEIVING | |
WO2007144083A3 (en) | Ache-nmda combination wafer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SD SE SG SI SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2002702595 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 11802003 Country of ref document: SK |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV2003-2568 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 2002702595 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV2003-2568 Country of ref document: CZ |
|
WWR | Wipo information: refused in national office |
Ref document number: PV2003-2568 Country of ref document: CZ |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2002702595 Country of ref document: EP Ref document number: JP |